Home India Ministry of Chemicals and Fertilizers Parliament Question: PLI scheme for Pharmaceutical Sectors...
Date: 2026-08-07 Category: LOKSABHA_QNA State: Union Government Country: India

Parliament Question: PLI scheme for Pharmaceutical Sectors

Issued by Ministry of Chemicals and Fertilizers · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task
Official Source Record View Original Source →
See Full Document Text
GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS LOK SABHA UNSTARRED QUESTION NO. 3402 TO BE ANSWERED ON THE 7TH AUGUST 2026 PLI scheme for Pharmaceutical Sectors 3402. Dr. Sharmila Sarkar: Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) whether it is a fact that, despite the launch of the PLI schemes for the pharmaceutical sector, the disbursement of funds has remained limited, if so, the details thereof; (b) the amount disbursed under the said schemes for Pharmaceutical sectors Bulk Drugs and Medical Devices during the last five years; (c) whether the Government has any plan to reform the Medical Devices PLI scheme, including shifting from an exclusively PLI framework to a hybrid model that incorporates both Component-Linked Incentives (CLI) and PLI to boost and attract more interested manufacturing companies; and (d) if so, the details thereof along with the steps taken in this regard? ANSWER THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SMT. ANUPRIYA PATEL) (a): Under the PLI Scheme for Pharmaceuticals, the performance period commenced in FY 2022-23. Out of the total financial outlay of ₹15,000 crore for this scheme, an incentive amount of ₹6,659 crore has been disbursed till March 2026. Under PLI Scheme for Bulk Drugs, out of the total outlay of ₹6,940 crore, an incentive amount of ₹87.70 crore has been disbursed till March 2026. Implementation of projects under the PLI Scheme for Bulk Drugs faced constraints on some accounts such as time consumed for land acquisition, environmental clearance, high utility costs, long gestation period for fermentation based bulk drugs etc. These factors collectively led to delayed commissioning of projects. Consequently, the disbursement of funds was affected as incentives are released based on sales of the eligible products manufactured from these projects.(b): The details of amount disbursed since the inception of the schemes are as follows: Sl. No. Name of scheme Amount disbursed (₹ in crore) Till March, 2026 1 PLI Scheme for Pharmaceuticals 6,659 2 PLI Scheme for Bulk Drugs 87.70 3 PLI Scheme for Medical Devices 266.64 (c) & (d): No, Sir. *****

Continue your research